Sinoway Industrial Co., Ltd.

Rabeprazole Sodium Intermediates 675198-19-3/117977-21-6 Rabeprazole Sodium Intermediates 675198-19-3/117977-21-6

Rabeprazole Sodium Intermediates 675198-19-3/117977-21-6
Related Products
  • NanoActive alpha lipoic acid (ALA) 1077-28-7

    1.Basic information of NanoActive alpha lipoic acidProduct Name: NanoActive alpha lipoic acid (ALA)Other Names: NanoActive THIOOCTIC ACIDAppearance: yellow, viscous and transparent liquidTest Method: ...

  • NanoActive Astaxanthin 472-61-7

    1.Basic information of NanoActive AstaxanthinProduct Name: NanoActive AstaxanthinOther Names: NanoActive AstaAppearance: reddish to dark red, viscous and transparent liquidTest Method: HPLCCAS NO.: 47...

  • NanoActive Curcumin 458-37-7

    1.Basic information of NanoActive CurcuminProduct Name: NanoActive CurcuminOther Names: NanoActive turmeric extractAppearance: yellow, viscous and transparent liquidTest Method: HPLCCAS NO.: 458-37-7S...

Basic Information of Rabeprazole Sodium Intermediates 675198-19-3/117977-21-6

  • CAS No of key intermediate.: 675198-19-3
  • 117977-21-6
  • EINECS No.: 117976-90-6
  • Purity: 99.0%
  • Application: Pharmaceutical intermediates
  • Appearance: White Powder, White Powder
  • Molecular Weight: 381.42400
  • Molecular formula: C18H20N3NaO3S

Usage of Rabeprazole Sodium Intermediates 675198-19-3/117977-21-6

  • Rabeprazole sodium, indications for the product is suitable for the following treatment: 1. Active duodenal ulcer; 2. Benign active gastric ulcer; 3. With clinical symptoms of aggressive or ulcerative gastric - esophageal reflux syndrome (GORD); 4 with appropriate antibiotics, can cure Helicobacter pylori-positive duodenal ulcer; 5 erosion or ulcerative gastric - esophageal reflux sign of maintenance treatment.

Note:

  1. The symptoms of treatment with sodium rabeprazole do not rule out the presence of stomach or esophageal cancer. Therefore, before using this product to start treatment should rule out the possibility of cancer. Although there are no obvious drug-related safety issues in age-sex matched controls with mild-to-moderate liver injury, the physician recommends special care when first treated with this product.
  2. Taking this product should be regularly carried out blood tests and blood biochemistry (such as liver enzyme test), found abnormal, that is, stop the medication, and timely treatment.
  3. Caution in patients with liver damage.

MORE_DETAIL Rabeprazole Sodium Intermediates 675198-19-3/117977-21-6

Basic Information of Rabeprazole Sodium Intermediates 675198-19-3/117977-21-6

  • CAS No of key intermediate.: 675198-19-3
  • 117977-21-6
  • EINECS No.: 117976-90-6
  • Purity: 99.0%
  • Application: Pharmaceutical intermediates
  • Appearance: White Powder, White Powder
  • Molecular Weight: 381.42400
  • Molecular formula: C18H20N3NaO3S

Usage of Rabeprazole Sodium Intermediates 675198-19-3/117977-21-6

  • Rabeprazole sodium, indications for the product is suitable for the following treatment: 1. Active duodenal ulcer; 2. Benign active gastric ulcer; 3. With clinical symptoms of aggressive or ulcerative gastric - esophageal reflux syndrome (GORD); 4 with appropriate antibiotics, can cure Helicobacter pylori-positive duodenal ulcer; 5 erosion or ulcerative gastric - esophageal reflux sign of maintenance treatment.

Note:

  1. The symptoms of treatment with sodium rabeprazole do not rule out the presence of stomach or esophageal cancer. Therefore, before using this product to start treatment should rule out the possibility of cancer. Although there are no obvious drug-related safety issues in age-sex matched controls with mild-to-moderate liver injury, the physician recommends special care when first treated with this product.
  2. Taking this product should be regularly carried out blood tests and blood biochemistry (such as liver enzyme test), found abnormal, that is, stop the medication, and timely treatment.
  3. Caution in patients with liver damage.
Related Articles
Leave a Message Email Us

we will contact you within 24 hours.

  • TEL:+86-0592-5854962
  • FAX:+86-0592-5854960
  • EMAIL: xie@china-sinoway.com
  • ADDRESS:Floor 16, Huicheng Business Center, No. 839, Xiahe Rd., Siming Dist. Xiamen, Fujian, China
//